CU104

Curacle Co., Ltd. · Phase 2 active Small molecule

CU104 is an investigational drug with unknown mechanism of action.

At a glance

Generic name	CU104
Sponsor	Curacle Co., Ltd.
Modality	Small molecule
Phase	Phase 2

Mechanism of action

Further information on CU104's mechanism of action is not available.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CU104 CI brief — competitive landscape report
CU104 updates RSS · CI watch RSS
Curacle Co., Ltd. portfolio CI